Literature DB >> 2422518

5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava.

M A Trevethick, W Feniuk, P P Humphrey.   

Abstract

5-Carboxamidotryptamine (5-CT) caused concentration dependent relaxation of isolated rings from the porcine vena cava contracted with either prostaglandin F2 alpha, histamine or alpha-methyl 5-hydroxytryptamine. Relaxation was not inhibited by propranolol (l microM), atropine (1 microM), indomethacin (3 microM), mepyramine (1 microM), cimetidine (1 microM), or cocaine (10 microM). Methysergide, but not cyproheptadine, was a competitive antagonist of the relaxant effect of 5-CT with a pA2 value of 7.88. 5-Carboxamidotryptamine also increased the intracellular levels of cyclic AMP, an effect which was antagonised by methysergide (apparent pA2: 7.95) but not cyproheptadine. The alpha-methyl analogue of 5-hydroxytryptamine did not cause relaxation or elevate cyclic AMP. These results suggest that 5-CT causes relaxation and elevation of cyclic AMP by interaction with a specific 5-hydroxytryptamine receptor which is '5-HT1-like'.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422518     DOI: 10.1016/0024-3205(86)90566-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.

Authors:  H E Connor; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

2.  Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines.

Authors:  G R Martin; P Leff; D Cambridge; V J Barrett
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

3.  5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery.

Authors:  S J MacLennan; M J Whittle; J C McGrath
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

4.  Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries.

Authors:  J A Terrón; A Falcón-Neri
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.

Authors:  A A Parsons; E T Whalley; W Feniuk; H E Connor; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

6.  Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava.

Authors:  M J Sumner; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.

Authors:  P P Humphrey; W Feniuk; M J Perren; H E Connor; A W Oxford; L H Coates; D Butina
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

8.  Evidence for excitatory 5-HT2-receptors on rat brainstem neurones.

Authors:  M Davie; L S Wilkinson; M H Roberts
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

9.  Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and β-phenylethylamine.

Authors:  M A Anwar; W R Ford; K J Broadley; A A Herbert
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.